GENAZZANI, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.913
AS - Asia 12.196
EU - Europa 9.951
SA - Sud America 1.565
Continente sconosciuto - Info sul continente non disponibili 343
AF - Africa 306
OC - Oceania 44
Totale 50.318
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.505
SG - Singapore 3.846
GB - Regno Unito 3.506
CN - Cina 3.314
IT - Italia 2.018
HK - Hong Kong 1.442
BR - Brasile 1.219
VN - Vietnam 1.168
SE - Svezia 823
DE - Germania 784
UA - Ucraina 592
FI - Finlandia 571
BD - Bangladesh 521
TR - Turchia 460
RU - Federazione Russa 406
FR - Francia 360
KR - Corea 330
IN - India 246
BG - Bulgaria 224
CA - Canada 190
ID - Indonesia 123
MX - Messico 120
AR - Argentina 118
ES - Italia 112
IQ - Iraq 105
NL - Olanda 104
PK - Pakistan 99
PL - Polonia 90
JP - Giappone 82
ZA - Sudafrica 79
IE - Irlanda 73
AE - Emirati Arabi Uniti 53
EG - Egitto 52
EC - Ecuador 50
IR - Iran 47
MA - Marocco 45
PH - Filippine 45
AU - Australia 40
LT - Lituania 39
VE - Venezuela 38
CL - Cile 34
CO - Colombia 34
MY - Malesia 34
SA - Arabia Saudita 31
BE - Belgio 29
TH - Thailandia 29
KE - Kenya 27
PE - Perù 27
UZ - Uzbekistan 27
CH - Svizzera 25
DZ - Algeria 24
RO - Romania 23
TN - Tunisia 23
AT - Austria 21
AZ - Azerbaigian 20
IL - Israele 20
UY - Uruguay 20
CZ - Repubblica Ceca 19
JO - Giordania 18
PT - Portogallo 18
GR - Grecia 16
PY - Paraguay 16
KG - Kirghizistan 15
NP - Nepal 15
DK - Danimarca 14
ET - Etiopia 13
HU - Ungheria 13
KZ - Kazakistan 13
PA - Panama 13
CR - Costa Rica 12
HN - Honduras 12
AL - Albania 11
JM - Giamaica 11
TT - Trinidad e Tobago 11
TW - Taiwan 11
BH - Bahrain 10
OM - Oman 10
BO - Bolivia 9
SN - Senegal 9
GH - Ghana 8
GT - Guatemala 8
LB - Libano 8
NG - Nigeria 8
EE - Estonia 7
NO - Norvegia 7
PR - Porto Rico 7
PS - Palestinian Territory 7
RS - Serbia 7
SY - Repubblica araba siriana 7
BY - Bielorussia 5
DO - Repubblica Dominicana 5
KH - Cambogia 5
MD - Moldavia 5
NI - Nicaragua 5
SI - Slovenia 5
YE - Yemen 5
GE - Georgia 4
KW - Kuwait 4
LK - Sri Lanka 4
MK - Macedonia 4
Totale 49.901
Salva come PNG Salva come JPEG
Città #
Fairfield 2.484
Southend 2.476
Ashburn 2.474
Singapore 2.253
Santa Clara 2.183
Woodbridge 1.616
Hong Kong 1.417
Houston 1.275
Jacksonville 1.155
Hefei 1.107
Chandler 1.040
Seattle 923
Wilmington 845
Ann Arbor 771
Cambridge 750
San Jose 699
Dearborn 655
Beijing 610
London 592
Nyköping 500
Los Angeles 490
Council Bluffs 438
Chicago 420
Ho Chi Minh City 375
The Dalles 364
Helsinki 344
Modena 340
Seoul 314
Hanoi 281
San Diego 237
Princeton 236
Buffalo 234
Sofia 217
Milan 215
Eugene 187
Lauterbourg 183
New York 175
Izmir 163
Salt Lake City 160
Dallas 130
Shanghai 113
Munich 112
Moscow 110
São Paulo 105
Des Moines 94
Columbus 84
Rome 84
Orem 77
Frankfurt am Main 75
Guangzhou 75
Bologna 73
Elk Grove Village 73
Boardman 72
Dublin 70
Bremen 67
Tampa 67
Redwood City 65
Jakarta 59
Tokyo 59
Haiphong 52
Kent 50
Atlanta 47
Da Nang 46
Warsaw 45
Phoenix 44
San Francisco 44
Mexico City 43
Norwalk 43
Miano 41
Naples 41
Rio de Janeiro 41
Istanbul 40
Turku 39
Montreal 38
Philadelphia 38
Baghdad 37
Falls Church 37
Detroit 36
Lancaster 35
Denver 33
Sterling 33
Chennai 32
Miami 32
North Bergen 32
Brooklyn 31
Florence 30
Johannesburg 30
Cagliari 29
Parma 28
Toronto 28
Boston 27
Mumbai 27
Redondo Beach 27
Amsterdam 26
Belo Horizonte 26
Dhaka 26
Verona 26
Turin 25
Brasília 24
Dongguan 24
Totale 34.295
Salva come PNG Salva come JPEG
Nome #
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea 670
Inositol as putative integrative treatment for PCOS 601
Effects of a Combination of Alpha Lipoic Acid and Myo-Inositol on Insulin Dynamics in Overweight/Obese Patients with PCOS. 522
Hypothalamic amenorrhea: from diagnosis to therapeutical approach. 419
Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback 408
Acetyl-L-Carnitine (ALC) administration positively affects reproductive axis in hypogonadotropic women with functional hypothalamic amenorrhea 385
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 384
Validation of italian version of the Women's Health Questionnaire: Assessment of quality of life of women from the general population and those attending menopause centers 381
Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia 347
One-year therapy with 10 mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu 341
Might DHEA be Considered a Beneficial Replacement Therapy in the Elderly ? 340
Estriol administration modulates luteinizing hormone secretion in women with functional hypothalamic amenorrhea 326
Diagnostic and therapeutic approach to hypothalamic amenorrhea 325
Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients 322
Neuroendocrine correlates of premenstrual syndrome: changes in the pulsatile pattern of plasma LH. 321
Use of metformin in the treatment of polycystic ovary syndrome 319
Effect of a 2-month treatment with Klamin®, a Klamath algae extract, on the general well-being, antioxidant profile and oxidative status of postmenopausal women 317
Neuroendocrine changes in luteal function in patients with premenstrual syndrome. 316
Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients 313
Improved insulin sensitivity and reproductive profile in overweight/obese PCOS patients undergoing integrative treatment with carnitines, L-arginine, L-cysteine and myo-inositol 312
Life events impact in patients with secondary amenorrhoea. 309
Inositol and human reproduction. From cellular metabolism to clinical use 308
Spontaneous endogenous pulsatile release of kisspeptin is temporally coupled with luteinizing hormone in healthy women 305
Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients 305
Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause 304
Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle 302
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome 300
Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications 297
Allopregnanolone concentrations and premenstrual syndrome 296
Acute infusion of naloxone, an opioid receptor antagonist, does not modify serum leptin concentrations in amenorrheic and healthy women 292
A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program. 290
Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance 289
Stressful life events and affective disorders inhibit pulsatile LH secretion in hypothalamic amenorrhea. 287
Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome 286
Color Doppler analysis in oligo and amenorrheic women with polycystic ovary syndrome 285
Advances in neurosteroids: Role in clinical practice 284
Combined myo-inositol and Banaba (1% Corosolic Acid) improve HOMA-IR and hepatic insulin extraction index in overweight and obese postmenopausal women 283
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. 279
Estimation of instantaneous secretory rates and intrinsic characteristics of luteinizing hormone secretion in women with Kallmann syndrome before and after estriol administration. 279
The relevance of inositols treatment for PCOS before and during ART 279
Actin Cytoskeleton Remodelling by Sex Steroids in Neurones 276
Effetto degli estratti di alga Klamath sul benessere e sui fenomeni di stress ossidativo nelle pazienti in menopausa 273
Subclinical Atherosclerosis at Peripheral Arteries in Obese Individuals. 273
Modulatory effects of l-carnitine plus l-acetyl-carnitine on neuroendocrine control of hypothalamic functions in functional hypothalamic amenorrhea (FHA) 272
Short-term estriol administration modulates hypothalamo-pituitary function in patients with functional hypothalamic amenorrhea (FHA) 271
Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets 270
Obesità e benessere: i rischi per la salute della donna obesa 268
Androgens Regulate T47D Cells Motility and Invasion through Actin Cytoskeleton Remodeling 266
Dall'uso del solo DHEA alla sua associazione con la terapia ormonale sostitutiva 264
Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution 259
La Sindrome Premestruale: clinica, fisiopatologia e indicazioni terapeutiche 259
Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS 257
Adrenal function under long-term raloxifene administration 252
Functional Hypothalamic Amenorrhea as Stress Induced Defensive System 252
Episodic secretion of activin A in pregnant women 251
Changes in Dopaminergic control of circulating melanocyte- stimulating hormone-related peptides at puberty. 245
EFFECT OF CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN ON PROSTAGLANDIN RELEASE FROM CULTURED MATERNAL DECIDUA AND ON CONTRACTILE ACTIVITY OF HUMAN MYOMETRIUM IN-VITRO 244
Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers 244
Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1) 241
Color Doppler analysis in lean and obese women with polycystic ovary syndrome. 241
Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both 241
Effects of cyproheptadine clorhydrate, a serotonin receptor antagonist, on endocrine parameters in weight-loss related amenorrhea 239
Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery 239
DHEA as a putative replacement therapy in the elderly 238
Corticotropin-releasing factor-binding protein: Origins and possible functions 237
FSH SECRETORY PATTERN AND DEGREE OF CONCORDANCE WITH LH IN AMENORRHEIC, FERTILE, AND POSTMENOPAUSAL WOMEN. 237
Assessment of the QoL in Italian menopausal women: Comparison between HRT users and non-users 235
Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women. 234
Long-term GnRH-agonist administration revealed a GnRH-independent mechanism stimulating FSH discharge in humans 234
Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia 234
Effects of estetrol on migration and invasion inT47-D breast cancer cells through the actin cytoskeleton 234
PULSATILE SECRETION OF GONADOTROPINS AND PROLACTIN DURING THE FOLLICULAR AND LUTEAL PHASES OF THE MENSTRUAL-CYCLE - ANALYSIS OF INSTANTANEOUS SECRETION RATE AND SECRETORY CONCOMITANCE 233
Effects of red clover extracts on breast cancer cell migration and invasion 232
Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome 230
Female precocious puberty, obesity and polycystic-like ovaries 230
Color Doppler hysterosalpingography in the diagnosis of tubal patency. 230
Neuroendocrinological Aspects of a Tailored Hormonal Contraception 229
Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders 229
Effects of Klamath Algae extract on psychological disorders and depression in menopausal women: a pilot study 228
Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea. 228
Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea 227
Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women 226
Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary syndrome 225
Which form of HRT should we choose? 223
Endocrine and clinical effects of myo-inositol administration in policystyc ovary syndrome. A randomized study. 223
Dydrogesterone exerts endothelial anti-inflammatory actions decreasing expression of leukocyte adhesion molecules 223
Effect of short term sibutramine on gonadotropin spontaneous pulsatile release in normogonadotropinemic amenorrheic subjects 222
The duration of prolactin secretory bursts from the pituitary is independent from both prolactin and gonadal steroid plasma levels in women and in men 222
Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea 221
The role of color doppler imaging in the diagnosis of polycystic ovary syndrome 221
Neuromodulatory role of opioidergic system on hypothalamus-pituitary-gonadal axis during puberty 220
Progestinici e fibromatosi uterina 219
Efficacy on menopausal neurovegetative symptoms and some plasma lipids blood levels of an herbal product containing isoflavones and other plant extracts 219
Acetyl-L-Carnitine effect on pituitary and plasma *-endorphin responsiveness to different chronic intermittent stressors. 218
Aspetti endocrini, diagnostici e terapeutici delle menimetrorragie in età perimenopausale. 217
Surgical technique of endometrioma excision impacts on the ovarian reserve. Single-port access laparoscopy versus multiport access laparoscopy: a case control study 217
. Opioid control of gonadotrophin secretion in humans. 217
Estrogen replacement therapy modulates spontaneous GH secretion but does not affect GH-RH-induced GH response and low T3 syndrome in women with hypothalamic amenorrhea associated to weight-loss 215
The role of kisspeptin/neurokinin B/dynorphin neurons in pathomechanism of vasomotor symptoms in postmenopausal women: from physiology to potential therapeutic applications 214
Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and GH-RH-induced GH secretion in postmenopausal women 213
Totale 27.779
Salva come PNG Salva come JPEG
Categoria #
all - tutte 203.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 203.492
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.428 66 583 352 284 63 116 277 198 345 211 533 400
2022/20233.137 348 269 172 271 391 517 52 285 422 45 150 215
2023/20242.303 92 145 141 152 551 197 242 315 36 72 145 215
2024/20257.938 334 105 80 608 1.507 1.010 355 487 1.067 720 763 902
2025/202616.663 1.044 714 1.610 1.644 2.192 1.300 1.906 897 1.678 1.562 1.127 989
2026/20271.406 1.406 0 0 0 0 0 0 0 0 0 0 0
Totale 50.318